Clin2
NCT07479641Likely a fitActive, not recruiting

Comparing Two HRS-1893 Tablets in Healthy People

Cardiomyopathy

Part of Heart & circulation clinical trials.

This trial tests whether two versions of an experimental tablet (HRS-1893) are absorbed the same way by the body. Healthy volunteers take one dose of each tablet at different times and have blood samples taken to compare effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
58 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • Your weight is between 99 and 198 pounds (45 to 90 kg) and your BMI (a measure of body fat) is between 19 and 28.
  • You are in general good health with no significant medical problems, including heart issues like fainting or abnormal ECG.
  • You do not have active infections like hepatitis B, C, syphilis, or HIV.
  • You haven't smoked more than 5 cigarettes a day or had more than about one daily drink in the past month, and you can avoid these during the study.
  • You are not taking any prescription or over-the-counter medications or herbs (except maybe acetaminophen if allowed).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07551167Recruiting· Phase 1
Safety Study of HRS-5765 in Healthy Adults

This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.

Beijing, Beijing Municipality
NCT07021963Recruiting· Phase 2
Long-term safety study of HRS-1893 for hypertrophic cardiomyopathy

This study tests the long-term safety of the drug HRS-1893 in people with hypertrophic cardiomyopathy who have already been in a previous HRS-1893 study. It helps doctors learn more about how safe the drug is over time.

Beijing, Beijing Municipality
NCT07752069Not yet recruiting· Phase 1
Comparing different versions of an experimental drug in healthy volunteers

This study tests different forms of an experimental medicine called HRS-5346 to see how the body absorbs them. It is for healthy people aged 18 to 45, and the results will help decide which version to use in future studies.

Beijing, Beijing Municipality
NCT07647783Recruiting· Phase 1
Safety Study of SYH2072 Tablet in Healthy Adults

This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.

Beijing, Beijing Municipality
NCT06506175Not yet recruiting· Phase 1
How different dosing conditions affect HRS9531 in healthy men

This trial is testing how different ways of taking an oral medication (HRS9531) affect the drug levels in the body. It is for healthy men to help find the best dosing conditions for future studies.

Qingdao, Shandong
NCT07656779Not yet recruiting· Phase 1
How HRS-1893 moves through the body in healthy men

This study looks at how a single dose of an investigational drug called HRS-1893 is processed and removed from the body in healthy men. You'll stay at the clinic and provide blood and urine samples for several days.

Wuxi, Jiangsu

Hear when a new Cardiomyopathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.